Jobs / United States / Astrazeneca Pharmaceuticals Lp
Director, IT Business Partnering – Oncology Business Unit (OBU) IT Data
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles4 certified filings for “Director, R&D IT - Dvlpmt & Late TA, IT Product Mgmt Clinic” (Data Scientists) in MD: $194k–$201k, median $194k. Most were filed at wage level IV (75%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Act as the trusted business partner to senior commercial leaders, connecting business strategy to technology, data and product outcomes across a complex, highly interdependent commercial ecosystem. This is primarily an advisory and relationship-led role – shaping Business Unit (BU) implementation and adoption plans, influencing investment decisions, advocating for product value, and ensuring the voice of the business is heard without acting as a proxy for users or assuming Product Manager decision rights. The role requires the hands-on delivery instincts to track cross-program dependencies personally, negotiate priorities and trade-offs among senior stakeholders, escalate issues appropriately, and step into the detail when needed to bring people together, simplify ways of working and unblock progress. The role sits at the intersection of commercial business stakeholders, Product, Platform and Data teams and external partners, in a fast-moving, regulated Pharma commercial environment where multiple systems, vendors and programs must move in step. This is a hybrid position with a requirement to work in the office three days a week. Accountabilities: Strategic Business Partnership • Act as the primary IT business partner for the commercial data & technology domain, building a trusted advisory relationship with senior commercial leaders. • Translate business strategy and commercial priorities into a coherent business-unit implementation and adoption plan, aligning with product roadmaps and shaping investment decisions based on business value rather than technical convenience. • Challenge and influence business thinking through a technology and data lens, bringing an outside-in perspective on what is possible and what is worth prioritising. • Educate and bring commercial leadership along on technology capability, risk and trade-offs, so decisions are made with a shared understanding rather than in translation. Product & Platform Partnering • Partner with IT Product Leads and Product Owners as an enabler and advocate: help shape and localise the product value story for the business unit, bring relevant business context and feedback into product discussions, and connect stakeholders with the right technical expertise without acting as a proxy for users or taking on product decision rights. • Create the conditions – clear BU implementation and adoption plans, resolved dependencies and unblocked risks – that enable Product Managers and Product Owners to make strong decisions in their own domain, while preserving direct engagement between product teams and the user community. • Build trusted working relationships with Product teams and the user community, ensuring business feedback is gathered directly from the appropriate users and translated into actionable context for product teams. Cross-Ecosystem Dependency Oversight • Maintain a live, working view of dependencies across commercial ecosystem elements – data platforms, commercial applications, analytics, master data, and vendor/agency deliverables – enough to spot conflicts before they become business risk. • Broker resolution between programs and Product teams when plans, timelines or resourcing conflict; establish clear issue-escalation paths and step into hands-on delivery detail when that is the fastest way to bring the right people together and unblock progress. • Provide senior stakeholders and governance forums with a clear, current view of interdependencies, risk, escalations and trade-offs, framed in business terms, and use local presence and cross-functional influence to simplify operational ways of working across the OBU. Complex Stakeholder Management • Manage multi-layered stakeholder relationships across commercial business leaders, technology, data, compl